
Massachusetts Life Sciences Center
Description
The Massachusetts Life Sciences Center (MLSC) is a quasi-public agency of the Commonwealth of Massachusetts, established in 2008 as a cornerstone of the state's ambitious 10-year, $1 billion Life Sciences Initiative. Its core mission is to promote the growth and development of the life sciences ecosystem within Massachusetts, focusing on job creation, fostering scientific research, and driving economic development. Unlike a traditional venture capital firm, MLSC operates as a strategic investor and facilitator, deploying public funds to catalyze innovation and expand the state's global leadership in biotechnology, pharmaceuticals, medical devices, and other related fields.
MLSC employs a diverse array of funding mechanisms, which include grants, loans, and tax incentives, rather than typical equity investments. These programs are designed to support a broad spectrum of activities, from foundational academic research to the commercialization of new technologies and the development of critical infrastructure. Key initiatives include the Capital Program, which funds state-of-the-art facilities and equipment; the Accelerator Program, providing grants to early-stage life sciences companies; and various programs supporting workforce development and internships. This multifaceted approach allows MLSC to address various needs across the entire life sciences value chain.
Since its inception, the MLSC has made a substantial impact on the Massachusetts economy and its life sciences cluster. The Center has invested over $800 million directly into the ecosystem, supporting a wide range of companies, research institutions, and academic centers. These strategic investments have been highly effective in attracting further capital, leveraging more than $4.3 billion in additional funding from other sources, including federal grants, private investment, and philanthropic contributions. This significant leverage underscores MLSC's role as a catalyst for growth, strengthening the state's position as a global hub for life sciences innovation and contributing to the creation of thousands of high-quality jobs.
Investor Profile
Massachusetts Life Sciences Center has backed more than 151 startups, with 1 new investments in the last 12 months alone. The firm has led 136 rounds, about 90% of its total and boasts 13 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Grant, Debt Financing, Convertible Note rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Health Care, Education, Biotechnology.
- Led 1 rounds in the past year.
- Typical check size: $25K – $1M.
Stage Focus
- Grant (88%)
- Debt Financing (8%)
- Convertible Note (4%)
Country Focus
- United States (100%)
Industry Focus
- Health Care
- Education
- Biotechnology
- Medical
- Higher Education
- Medical Device
- Secondary Education
- Universities
- Primary Education
- Manufacturing
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.